2.07

2.48% 0.05

After Hours: 2.00 -0.07 -3.38%

Virax Biolabs Group Ltd (VRAX)

Overview News Price History Discussions Forecast

Virax Biolabs Group Ltd stock is traded at $2.07, with a volume of 59,707. It is up +2.48% in the last 24 hours and down -9.21% over the past month. Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Previous Close:

$2.02

Open:

24h Volume:

59,707

Relative Volume:

0.02

Market Cap:

$8.86M

Revenue:

$79,300

Net Income/Loss:

$-6.92M

P/E Ratio:

-3.2435

EPS:

-0.6382

Net Cash Flow:

$-5.34M

1W Performance:

+10.11%

1M Performance:

-9.21%

6M Performance:

+130.00%

1Y Performance:

+810.29%

1-Day Range:

$1.97

$2.12

1-Week Range:

$1.82

$2.18

52-Week Range:

$0.1299

$8.9999

Virax Biolabs Group Ltd Stock (VRAX) Company Profile

Name

Virax Biolabs Group Ltd

Sector

Healthcare (1200)

Industry

Biotechnology (682)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

VRAX's Discussions on Twitter

Compare VRAX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VRAX Virax Biolabs Group Ltd	2.07	8.86M	79,300	-6.92M	-5.34M	-0.6382
VRTX Vertex Pharmaceuticals Inc	464.56	119.70B	10.63B	-479.80M	-1.35B	13.33
REGN Regeneron Pharmaceuticals Inc	754.87	82.75B	13.85B	4.65B	3.32B	35.06
ARGX Argen X Se Adr	614.59	36.73B	1.86B	-40.29M	-1.28B	-4.16
ALNY Alnylam Pharmaceuticals Inc	253.74	32.53B	2.09B	-332.26M	16.06M	-4.14
BNTX Biontech Se Adr	120.72	28.50B	3.30B	-501.07M	1.03B	11.54

Virax Biolabs Group Ltd Stock (VRAX) Latest News

Nov 20, 2024

Virax Biolabs Sees Asset Growth Amid Financial Loss - TipRanks

Nov 20, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Virax Biolabs Group Ltd - GuruFocus.com

Nov 15, 2024

Nov 01, 2024

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know - MSN

Oct 26, 2024

Oct 23, 2024

Virax Biolabs announces distribution agreement with Europa Biosite - TipRanks

Oct 23, 2024

Virax Biolabs Expands Reach with Europa Biosite Deal - TipRanks

Oct 23, 2024

EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland - Yahoo Finance

Oct 23, 2024

Oct 04, 2024

Pre-market Movers: ALZN, VRAX, APDN, LQDA... - RTTNews

Oct 04, 2024

Oct 03, 2024

Analyzing the Impact of Earnings Reports on Virax Biolabs Group Ltd Inc. (VRAX) Price Performance - The InvestChronicle

Oct 03, 2024

Daily Progress: Virax Biolabs Group Ltd (VRAX) Gain 14.20, Closing at 1.85 - The Dwinnex

Oct 03, 2024

Sep 30, 2024

Virax Biolabs Plans New Share Offering - TipRanks

Sep 30, 2024

Sep 27, 2024

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session - MSN

Sep 27, 2024

Sep 25, 2024

Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 72.2% in September - Defense World

Sep 25, 2024

Charting the Course: Virax Biolabs Group Ltd’s VRAX Stock Prospects - The InvestChronicle

Sep 25, 2024

Sep 23, 2024

How did Virax Biolabs Group Ltd (VRAX) fare last session? - US Post News

Sep 23, 2024

Daily Market Movement: Virax Biolabs Group Ltd (VRAX) Sees a -3.56 Decrease, Closing at 2.44 - The Dwinnex

Sep 23, 2024

Sep 17, 2024